Indivior PLC
Change company Symbol lookup
Select an option...
INVVY Indivior PLC
OSUR OraSure Technologies Inc
QUOT Quotient Technology Inc
DUK Duke Energy Corp
WAFD Washington Federal Inc
REML Credit Suisse X-Links Monthly Pay 2xLeveraged Mortgage REIT ETN
$NQG3010LMT Nasdaq Global Banks Large Mid Cap To
SRTS Sensus Healthcare Inc
LITB LightInTheBox Holding Co Ltd
MZA BlackRock MuniYield Arizona
Go

Health Care : Pharmaceuticals | Small Cap Blend
Based in United Kingdom
Company profile

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine and naloxone), and Subutex Tablet (buprenorphine). Its other products include RBP-6000 in ATRIGEL, RBP-7000 risperidone monthly depot, Arbaclofen placarbil for alcohol use disorder (AUD), Intranasal naloxone for treatment of opioid overdose and RBP-8000 cocaine esterase for cocaine intoxication. Its RBP-6000 buprenorphine monthly depot is developed for the treatment of opioid use disorder. Its RBP-7000 risperidone monthly depot is developed for treatment of schizophrenia.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$7.92
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
75,217
0

Tepper's Appaloosa loads up on new stakes in AT&T, Visa, PayPal, Disney, and Mastercard

5:08 pm ET August 14, 2020 (MarketWatch)
Print

David Tepper's fund Appaloosa took a number of new stakes in mostly communication services, technology an payment platforms over the past 45-day period, according to regulatory filings submitted to the Securities and Exchange Commission on Friday, known as 13Fs. Appaloosa acquired more than 9 million shares in AT&T (T) worth $274 million, but also picked up 840,000 shares of Visa Inc. (V) valued at $162.3 million, 545,000 shares of Mastercard (MA) worth $161 million, and 870,000 shares of payments company PayPal Holdings (PYPL), or $151.6 million. Tepper's fund also scooped up 1.2 million shares of Disney at $133 million and 1.9 million shares of food-services company Sysco Corp. (SYY) worth $102.5 million. Appaloosa also purchased 1.6 million shares of Altria Group Inc. for about $61 million, representing a new position in the tobacco company. Incidentally, while the 13F fillings for Warren Buffett's Berkshire Hathaway (BRKA)(BRKA) was unloading more than a quarter of its position in Wells Fargo & Co. (WFC), Tepper boosted his position by more than 170%, buying 1.2 million shares of the San Francisco bank, representing 0.8% of Appaloosa's overall portfolio from 0.6%. The company also picked up 1.4 million shares of Emerson Electric Co. (EMR), worth $87 million, about 1.5% of the fund's portfolio. Large investors must disclose long stock positions held at the end of a quarter 45 days later in a 13F filing with the SEC, which means such filings are merely a snapshot of an investor holdings at a given point.

-Mark DeCambre; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 14, 2020 17:08 ET (21:08 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.